Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 14/20 | 0.47 |
| ▸ | GAA | P10253 | 14/20 | 0.47 |
| ▸ | SI | P14410 | 14/20 | 0.47 |
| ▸ | MGAM2 | Q2M2H8 | 14/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | CBFB | Q13951 | 1/20 | 0.45 |
| ▸ | AURKA | O14965 | 1/20 | 0.44 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.44 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.44 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.44 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6679316 | 0.83 | CBFB (0.44) | CBFB | |
| SCHEMBL1170892 | 0.73 | MGAM (0.71) | MGAMGAASIMGAM2ESR1 | |
| SCHEMBL14844694 | 0.68 | KDM4E (0.59) | MGAMGAASIMGAM2ESR1 | |
| SCHEMBL28504618 | 0.68 | MGAM (0.51) | MGAMGAASIMGAM2ESR1 | |
| SCHEMBL30061961 | 0.68 | MGAM (0.51) | MGAMGAASIMGAM2ESR1 | |
| SCHEMBL11304574 | 0.68 | GSR (0.45) | MAPK10 | |
| SCHEMBL2578465 | 0.67 | CBFB (0.73) | MGAMGAASIMGAM2ESR1 | |
| SCHEMBL10285823 | 0.67 | MGAM (0.50) | MGAMGAASIMGAM2ESR1 | |
| SCHEMBL5074029 | 0.66 | MGAM (0.76) | MGAMGAASIMGAM2ESR1 | |
| SCHEMBL30615069 | 0.66 | MGAM (0.76) | MGAMGAASIMGAM2ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121674282-A | Method for preparing ultraviolet absorbent by utilizing Gong Pi live cocci Dermacoccus nishinomiyaensis and application | 上海交通大学三亚崖州湾深海科技研究院 | 2026-03-17 | — | — | CN | disclosed |
| EP-4036246-B1 | A METHOD FOR TRANSPARENTIZING BIOLOGICAL TISSUE IN A LIVING STATE | UNIV OSAKA (JP) | 2025-04-09 | — | — | EP | disclosed |
| US-20250041430-A1 | CONJUGATE COMPOUND AND METHOD FOR PRODUCING CONJUGATE COMPOUND | NIPPON SHOKUBAI CO., LTD. (JP) | 2025-02-06 | — | — | US | disclosed |
| CN-113195003-B | Drug delivery system using solution | 国立大学法人京都大学 | 2024-12-31 | — | — | CN | disclosed |
| US-20240358625-A1 | STABILIZATION OF MYCOSPORINE-LIKE AMINO ACIDS | NAGASE & CO., LTD. (JP) | 2024-10-31 | — | — | US | disclosed |
| US-20240209008-A1 | METHOD FOR PRODUCING ASYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING SYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING PHOSPHORIC ACID ESTER, AND METHOD FOR PRODUCING ORGANOPHOSPHORUS COMPOUND | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2024-06-27 | — | — | US | disclosed |
| EP-4385506-A1 | STABILIZATION OF MYCOSPORINE-LIKE AMINO ACID | Nagase & Co., Ltd. (JP) | 2024-06-19 | — | — | EP | disclosed |
| CN-118103479-A | Organic solid up-conversion material | 出光兴产株式会社 | 2024-05-28 | — | — | CN | disclosed |
| CN-117750952-A | Stabilization of cephalosporin amino acids | 长濑产业株式会社 | 2024-03-22 | — | — | CN | disclosed |
| EP-4303222-A1 | METHOD FOR PRODUCING ASYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING SYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING PHOSPHORIC ACID ESTER, AND METHOD FOR PRODUCING ORGANOPHOSPHORUS COMPOUND | Tokyo Institute of Technology (JP) | 2024-01-10 | — | — | EP | disclosed |
| US-9290613-B2 | Polylactic acid resin composition and additive for polylactic acid resin | BIOBASE CORPORATION (JP) | 2016-03-22 | — | — | US | disclosed |
| US-20120255853-A1 | Method for Producing Superoxide, Method for Evaluating Superoxide Scavenging Ability, Device for Producing Superoxide, and Device for Evaluating Superoxide Scavenging Ability | SAPPORO MEDICAL UNIVERSITY (JP) | 2012-10-11 | — | — | US | disclosed |
| EP-2388285-A1 | POLYLACTIC ACID RESIN COMPOSITION AND ADDITIVE FOR POLYLACTIC ACID RESIN | Biobase Corporation (JP) | 2011-11-23 | — | — | EP | disclosed |
| US-20110275749-A1 | Polylactic Acid Resin Composition and Additive for Polylactic Acid Resin | BIOBASE CORPORATION (JP) | 2011-11-10 | — | — | US | disclosed |
| US-8038052-B2 | Retractable dual-purpose file folder | HUANG JAMES C | 2011-10-18 | — | — | US | disclosed |
| US-20080248514-A1 | ELECTROCHEMICAL METHOD FOR GLUCOSE QUANTIFICATION, GLUCOSE DEHYDROGENASE COMPOSITION, AND ELECTROCHEMICAL SENSOR FOR GLUCOSE MEASUREMENT | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 2008-10-09 | — | — | US | disclosed |
| EP-1085861-A1 | INHIBITORS OF NITRIC OXIDE SYNTHASE | Advanced Medicine, Inc. (US) | 2001-03-28 | — | — | EP | disclosed |
| WO-1999063988-A9 | INHIBITORS OF NITRIC OXIDE SYNTHASE | ADVANCED MEDICINE INC (US) | 2000-05-04 | — | — | WO | disclosed |
| WO-1999063988-A1 | INHIBITORS OF NITRIC OXIDE SYNTHASE | ADVANCED MEDICINE, INC. (US) | 1999-12-16 | — | — | WO | disclosed |
| EP-0952184-A1 | Rubber composition | Continental Aktiengesellschaft (DE) | 1999-10-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250041430-A1 | CONJUGATE COMPOUND AND METHOD FOR PRODUCING CONJUGATE COMPOUND | C9, C3AR1, C5AR1 | MGAM 1417/4885GAA 2578/4885SI 435/4885 |
| US-20240358625-A1 | STABILIZATION OF MYCOSPORINE-LIKE AMINO ACIDS | GDA, MYCBP, MYC | MGAM 25/4885GAA 334/4885SI 3639/4885 |
| US-20240209008-A1 | METHOD FOR PRODUCING ASYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING SYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING PHOSPHORIC ACID ESTER, AND METHOD FOR PRODUCING ORGANOPHOSPHORUS COMPOUND | HAO2, PLCB1, PHPT1 | MGAM 1603/4885GAA 2792/4885SI 1497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.